EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches

Kexin Cai, Haoyue Jiang, Yuanming Zou, Chunyu Song, Kexin Cao, Shuxian Chen, Yanjiao Wu, Zhaobo Zhang, Danxi Geng, Naijin Zhang, Bo Liu, Guozhe Sun und 5 weitere

Pharmacological Research · 2024-08 · 206 · 107281

DOI: 10.1016/j.phrs.2024.107281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-08. Verfasst von Kexin Cai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, Peopl…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cardiovascular Diseases. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 284 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) have a complex pathogenesis and pose a major threat to human health. Cardiomyocytes have a low regenerative capacity, and their death is a key factor in the morbidity and mortality of many CVDs. Cardiomyocyte death can be regulated by specific signaling pathways known as programmed cell death (PCD), including apoptosis, necroptosis, autophagy, pyroptosis, and ferroptosis, etc. Abnormalities in PCD can lead to the development of a variety of cardiovascular diseases, and there are also molecular-level interconnections between different PCD pathways under the same cardiovascular disease model. Currently, the link between programmed cell death in cardiomyocytes and cardiovascular disease is not fully understood. This review describes the molecular mechanisms of programmed death and the impact of cardiomyocyte death on cardiovascular disease development. Emphasis is placed on a summary of drugs and potential therapeutic approaches that can be used to treat cardiovascular disease by targeting and blocking programmed cell death in cardiomyocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCardiovascular DiseasesHumansAnimalsApoptosisSignal TransductionCardiovascular Agents

Stichwörter der Autor:innen

Atorvastatin (PubChem CID: 60823)CardiomyocyteCardiovascular diseasesCarvedilol (PubChem CID: 2585)Dapagliflozin (PubChem CID: 9887712)Dexmedetomidine (PubChem CID:6918081)DrugFluvastatin (PubChem CID: 23679527)Melatonin (PubChem CID:896)Probucol (PubChem CID: 4912)Programmed cell deathSP600125 (PubChem CID: 8515)Scutellarin (PubChem CID: 185617)TreatmentTrimetazidine (PubChem CID: 83201)

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China.
  • Department of Cardiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China; Institute of health sciences, China medical uni…
  • The first hospital of China Medical University, Department of cardiac surgery, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China. Electronic address: bliu17@cmu.edu.cn.
  • Department of Cardiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China. Electronic address: gzhsun66@163.com.
  • Department of clinical pharmacology, College of Pharmacy, China medical university, 77 Puhe Road, Shenbei New District, Shenyang, Liaoning 110001, People's Republic of China. Electronic address: 2440762568@qq.com.
  • Department of Cardiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China. Electronic address: drzhaoli123@163.com.

Zitieren

APA

Cai, K., Jiang, H., Zou, Y., Song, C., Cao, K., Chen, S., Wu, Y., Zhang, Z., Geng, D., Zhang, N., Liu, B., Sun, G., Tang, M., Li, Z., Zhang, Y., Sun, Y., & Zhang, Y. (2024). Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Pharmacological Research, 206, 107281. https://doi.org/10.1016/j.phrs.2024.107281

Vancouver

Cai K, Jiang H, Zou Y, Song C, Cao K, Chen S, et al. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Pharmacological Research. 2024;206:107281. doi:10.1016/j.phrs.2024.107281

BibTeX
@article{Cai2024,
  author = {Cai, Kexin and Jiang, Haoyue and Zou, Yuanming and Song, Chunyu and Cao, Kexin and Chen, Shuxian and Wu, Yanjiao and Zhang, Zhaobo and Geng, Danxi and Zhang, Naijin and Liu, Bo and Sun, Guozhe and Tang, Man and Li, Zhao and Zhang, Yixiao and Sun, Yingxian and Zhang, Ying},
  title = {Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches},
  journal = {Pharmacological Research},
  year = {2024},
  volume = {206},
  pages = {107281},
  doi = {10.1016/j.phrs.2024.107281}
}
Kostenlos starten →